GILEAD SCIENCES, INC. is 4.8x more valuable than Revolution Medicines, Inc. by market capitalization ($155.93 B vs $32.71 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GILD | RVMD |
|---|---|---|
| Market cap | $155.93 B | $32.71 B |
| US-listed rank | #98 | #439 |
| Revenue (latest FY) | $29.44B | $0.00 |
| Net income (latest FY) | $8.51B | -$1.13B |
| Net margin | 28.9% | - |
| P/E (trailing FY) | 18.3 | - |
| SEC filings | 981 | 782 |
GILEAD SCIENCES, INC. is 4.8x more valuable than Revolution Medicines, Inc. by market capitalization ($155.93 B vs $32.71 B).
In their latest fiscal years, GILEAD SCIENCES, INC. reported $29.44B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: GILEAD SCIENCES, INC. and Revolution Medicines, Inc., or browse the full rankings.